Marcus J Schultz Selected Research

Lung Injury

1/2022	Can nebulised HepArin Reduce morTality and time to Extubation in patients with COVID-19 Requiring invasive ventilation Meta-Trial (CHARTER-MT): Protocol and statistical analysis plan for an investigator-initiated international meta-trial of prospective randomised clinical studies.
1/2022	Lung- and Diaphragm-Protective Ventilation by Titrating Inspiratory Support to Diaphragm Effort: A Randomized Clinical Trial.
11/2021	Effect of patient-ventilator asynchrony on lung and diaphragmatic injury in experimental acute respiratory distress syndrome in a porcine model.
11/2021	Epidemiological Characteristics, Ventilator Management, and Clinical Outcome in Patients Receiving Invasive Ventilation in Intensive Care Units from 10 Asian Middle-Income Countries (PRoVENT-iMiC): An International, Multicenter, Prospective Study.
8/2021	Diagnosis of acute respiratory distress syndrome (DARTS) by bedside exhaled breath octane measurements in invasively ventilated patients: protocol of a multicentre observational cohort study.
1/2021	Mechanical Power Correlates With Lung Inflammation Assessed by Positron-Emission Tomography in Experimental Acute Lung Injury in Pigs.
12/2020	The effects of tidal volume size and driving pressure levels on pulmonary complement activation: an observational study in critically ill patients.
12/2020	Alkaline phosphatase in pulmonary inflammation-a translational study in ventilated critically ill patients and rats.
11/2020	Pulmonary levels of biomarkers for inflammation and lung injury in protective versus conventional one-lung ventilation for oesophagectomy: A randomised clinical trial.
1/2020	Myocardial Function during Low versus Intermediate Tidal Volume Ventilation in Patients without Acute Respiratory Distress Syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus J Schultz Research Topics

Disease

108	Critical Illness (Critically Ill) 01/2022 - 01/2004
70	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2022 - 07/2004
65	Lung Injury 01/2022 - 10/2006
64	Sepsis (Septicemia) 01/2022 - 05/2003
62	Pneumonia (Pneumonitis) 01/2022 - 01/2002
57	Inflammation (Inflammations) 01/2022 - 04/2003
52	Infections 01/2022 - 04/2003
32	COVID-19 10/2022 - 01/2020
30	Acute Lung Injury 12/2016 - 05/2003
23	Ventilator-Induced Lung Injury 01/2021 - 07/2008
16	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 10/2006
16	Hypoxia (Hypoxemia) 11/2021 - 03/2008
13	Ventilator-Associated Pneumonia 01/2022 - 01/2004
12	Pulmonary Atelectasis 11/2021 - 10/2012
11	Hypoglycemia (Reactive Hypoglycemia) 07/2017 - 01/2006
10	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 04/2008
10	Pulmonary Edema 11/2021 - 01/2009
10	Body Weight (Weight, Body) 01/2021 - 01/2010
9	Wounds and Injuries (Trauma) 01/2021 - 02/2008
8	Shock 04/2022 - 05/2008
8	Pneumococcal Pneumonia 11/2021 - 01/2008
8	Hypothermia 06/2020 - 01/2009
7	Hemorrhage 01/2021 - 01/2007
7	Heart Arrest (Cardiac Arrest) 12/2020 - 01/2008
6	Hyperoxia 01/2021 - 01/2014
6	Burns 01/2021 - 01/2011
6	Pneumothorax 12/2020 - 05/2015
6	Transfusion-Related Acute Lung Injury 10/2012 - 02/2010
5	Septic Shock (Toxic Shock Syndrome) 01/2021 - 01/2008
4	Human Influenza (Influenza) 01/2021 - 03/2010
4	Endotoxemia 12/2020 - 04/2010
4	Diabetes Mellitus 05/2020 - 01/2006
4	Peritonitis 01/2016 - 11/2006
4	Renal Insufficiency (Renal Failure) 08/2011 - 08/2005
3	Thrombosis (Thrombus) 01/2022 - 01/2007
3	Bacteremia 11/2021 - 10/2014
3	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2007
3	Hypercapnia 12/2020 - 03/2008
3	Anemia 02/2020 - 05/2018
3	Cross Infection (Nosocomial Infection) 01/2020 - 08/2015

Drug/Important Bio-Agent (IBA)

54	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2006
22	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2003
21	Oxygen (Dioxygen)IBA 01/2022 - 11/2006
21	CytokinesIBA 01/2022 - 01/2002
19	LipopolysaccharidesIBA 06/2021 - 07/2010
19	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2006
18	AnticoagulantsIBA 01/2021 - 05/2003
16	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2007
13	Protein CIBA 11/2017 - 09/2005
12	FibrinIBA 01/2022 - 04/2003
12	AntithrombinsIBA 11/2017 - 11/2006
10	Thrombin FDA Link 09/2015 - 05/2003
9	Thromboplastin (Tissue Factor)IBA 11/2018 - 06/2006
8	Biological ProductsIBA 01/2022 - 01/2018
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 08/2009
8	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2010
8	Insulin (Novolin)FDA Link 07/2017 - 01/2006
7	Receptor for Advanced Glycation End ProductsIBA 11/2020 - 02/2010
7	Blood Glucose (Blood Sugar)IBA 01/2017 - 07/2011
6	Complement System Proteins (Complement)IBA 12/2020 - 01/2016
6	danaparoid (Orgaran)FDA Link 11/2017 - 01/2007
6	ChemokinesIBA 07/2015 - 01/2002
6	Plasminogen Activators (Plasminogen Activator)IBA 10/2012 - 06/2006
5	MacrolidesIBA 01/2022 - 07/2004
5	CreatinineIBA 01/2021 - 11/2009
5	Volatile Organic CompoundsIBA 04/2019 - 01/2014
5	lipoprotein-associated coagulation inhibitor (TFPI)IBA 11/2017 - 02/2007
4	Neuromuscular Blocking AgentsIBA 01/2021 - 08/2005
4	Acetylcysteine (Siran)FDA LinkGeneric 12/2020 - 01/2006
4	Interleukin-8 (Interleukin 8)IBA 12/2020 - 11/2009
4	Hypnotics and Sedatives (Sedatives)IBA 10/2020 - 01/2007
4	Lactic Acid (Lactate)FDA LinkGeneric 10/2020 - 01/2006
4	Saline SolutionIBA 03/2020 - 01/2009
4	AntibodiesIBA 01/2018 - 10/2007
4	Fibrin Fibrinogen Degradation ProductsIBA 10/2011 - 01/2009
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 04/2022 - 06/2006
3	Messenger RNA (mRNA)IBA 11/2021 - 05/2017
3	C-Reactive ProteinIBA 09/2021 - 12/2015
3	CatecholaminesIBA 12/2020 - 01/2006
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 11/2020 - 02/2010
3	Transferrin (beta 2 Transferrin)IBA 02/2020 - 05/2018
3	IronIBA 02/2020 - 05/2018

Therapy/Procedure

95	Artificial Respiration (Mechanical Ventilation) 01/2022 - 04/2005
45	Therapeutics 01/2022 - 05/2003
44	Mechanical Ventilators (Ventilator) 01/2022 - 11/2005
35	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 04/2022 - 10/2006
22	Critical Care (Surgical Intensive Care) 10/2022 - 09/2005
18	Length of Stay 01/2022 - 01/2006
12	Glycemic Control 01/2017 - 09/2005
9	Resuscitation 01/2021 - 01/2010
7	Tracheostomy 01/2021 - 01/2020
7	Induced Hypothermia 01/2020 - 01/2008
6	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 01/2007
5	Continuous Renal Replacement Therapy 05/2008 - 01/2006
4	Noninvasive Ventilation 01/2021 - 04/2012
4	General Anesthesia 01/2021 - 01/2014
4	Extracorporeal Membrane Oxygenation 10/2020 - 11/2016
3	Immunomodulation 01/2022 - 07/2004
3	Aftercare (After-Treatment) 01/2021 - 08/2012
3	Central Venous Catheters 01/2021 - 11/2011